Estimating the generated business value of big data analytics dashboard for end users at a pharmaceutical company

Abstract

The company introduced BDA to support clinical trials with an in-house-built dashboard and application on operational data. As the technology is still new to the industry, no long-term studies have demonstrated the value of BDA for a company. Traditional key performance metrics are unsuitable for measuring the value since BDA technology is more than just a system or application. Every year, the project team behind the big data dashboard has been asked to show the application’s value but has struggled to do so.